Clinical management of rising prostate-specific antigen after radical retropubic prostatectomy

J. Kellogg Parsons; Alan W. Partin

Clinical management of rising prostate-specific antigen after radical retropubic prostatectomy

J. Kellogg Parsons, Alan W. Partin

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Approximately 40% of men diagnosed with prostate cancer will undergo radical prostatectomy.1 Of these, 15% to 46% will manifest an isolated, asymptomatic rise in postoperative PSA within 15 years. This phenomenon is referred to as biochemical recurrence. Since an estimated 75,000 radical prostatectomies are performed annually in the US, biochemical recurrence after prostatectomy represents a healthcare issue of considerable magnitude, affecting several thousand men each year.2.

Original language	English (US)
Title of host publication	Prostate Cancer
Subtitle of host publication	Principles and Practice
Publisher	CRC Press
Pages	747-754
Number of pages	8
ISBN (Electronic)	9780203624326
ISBN (Print)	9781841844589
State	Published - Jan 1 2005
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Cite this

@inbook{cb1431336c6a4e2d81f07ff0e3e3e8ea,

title = "Clinical management of rising prostate-specific antigen after radical retropubic prostatectomy",

abstract = "Approximately 40% of men diagnosed with prostate cancer will undergo radical prostatectomy.1 Of these, 15% to 46% will manifest an isolated, asymptomatic rise in postoperative PSA within 15 years. This phenomenon is referred to as biochemical recurrence. Since an estimated 75,000 radical prostatectomies are performed annually in the US, biochemical recurrence after prostatectomy represents a healthcare issue of considerable magnitude, affecting several thousand men each year.2.",

author = "{Kellogg Parsons}, J. and Partin, {Alan W.}",

note = "Publisher Copyright: {\textcopyright} 2006 by Taylor & Francis Group, LLC.",

year = "2005",

month = jan,

day = "1",

language = "English (US)",

isbn = "9781841844589",

pages = "747--754",

booktitle = "Prostate Cancer",

publisher = "CRC Press",

address = "United States",

}

TY - CHAP

T1 - Clinical management of rising prostate-specific antigen after radical retropubic prostatectomy

AU - Kellogg Parsons, J.

AU - Partin, Alan W.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Approximately 40% of men diagnosed with prostate cancer will undergo radical prostatectomy.1 Of these, 15% to 46% will manifest an isolated, asymptomatic rise in postoperative PSA within 15 years. This phenomenon is referred to as biochemical recurrence. Since an estimated 75,000 radical prostatectomies are performed annually in the US, biochemical recurrence after prostatectomy represents a healthcare issue of considerable magnitude, affecting several thousand men each year.2.

AB - Approximately 40% of men diagnosed with prostate cancer will undergo radical prostatectomy.1 Of these, 15% to 46% will manifest an isolated, asymptomatic rise in postoperative PSA within 15 years. This phenomenon is referred to as biochemical recurrence. Since an estimated 75,000 radical prostatectomies are performed annually in the US, biochemical recurrence after prostatectomy represents a healthcare issue of considerable magnitude, affecting several thousand men each year.2.

UR - http://www.scopus.com/inward/record.url?scp=84975791207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975791207&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84975791207

SN - 9781841844589

SP - 747

EP - 754

BT - Prostate Cancer

PB - CRC Press

ER -

Clinical management of rising prostate-specific antigen after radical retropubic prostatectomy

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this